Not surprisingly, all investors face the same problem - deciding on who you can trust to look after and grow your investments and hard earned savings.
You need to be sure you can work with them, you need to know they will have your very best interests at heart and, most importantly, you need to be able to rest assured that they are always working on your behalf to improve your financial situation in the face of an increasingly complex and sophisticated investment market.
As the principals, we formed Axiom Wealth because we were disenchanted by the unnecessary bureaucracy and lack of transparency that are common place in the financial planning industry.
We are a medium-sized, energetic and professional team with our hearts and minds focused entirely on our client's future prosperity.
It is important to view the historic performance of your investments against the backdrop of how investment markets more generally have behaved. In this regard, the following contextual information, sourced primarily from our independent research house, Lonsec, is relevant.
Australian shares rose 2.8% in August. IT and Consumer Discretionary were the top returning sectors. Once again earnings season was dominated by the dire effects of COVID-19 as companies cut dividends and increased cash holdings. Appen (-2.6%) reported 1H20 results in September, with revenue growth of 25% on the same quarter last year. Relevance was the largest contributor, with revenue growth of 24%, however Speech and Image revenue fell 20% following a breakout result in 1H19.
IOOF Holdings (+1.5%) announced the acquisition of MLC for $1.44 billion, which will be partially funded via an entitlement offer and placement. A2 Milk Company (-11.8%) reported revenue and EBITDA growth of 33% on the prior corresponding period. Infant formula was the main driver of the result, supported by a 65.1% increase in Chinese sales. CSL (+5.9%) announced in September it had signed Heads of Agreements with the Australian Government and AstraZeneca to supply two potential COVID-19 vaccines within Australia following successful clinical trials, however, AstraZeneca briefly halted the trial to investigate an adverse reaction from a study participant in the UK. However, the trial has now been resumed.
Global equities
The S&P 500 Index rose 7.2% in US dollar terms, ending August at record highs and fully recovered from its March low. The rebound in global equities has been led by large cap growth companies, which have benefitted from the persistent low rate, low growth environment.
However, the start of September saw some pressure taken out of extended valuations, especially among US technology shares. In the first week, the NASDAQ fell 6.4% in price terms from Wednesday's record high. Electric car manufacturer Tesla gained 74.2% in August and fell 16.1% in the first week of September but was still 400% higher on the start of 2020.
×February started with a bang, with the US market experiencing its biggest pull back since early 2016. The pullback occurred on the back of fears of rising inflation and interest rates as wage growth data in the US ticked up. Furthermore, volatility traders were unwinding their short volatility trades creating volatility in markets. Previously we have discussed the low level of volatility in markets and that at some stage volatility would return to more normal levels.
When the COVID-19 crisis hit financial markets, we decided to hold more frequent Investment meetings and provide you with regular updates on our thoughts and discussions from a portfolio perspective.
The key question we asked ourselves during these meetings was: when is the right time to take a more positive tilt towards risk assets given the material market pull-back we have experienced? When we assessed our Dynamic Asset Allocation (DAA) models, it was clear that valuations across most risk assets had improved materially over recent months. The biggest unknown was to what extent the market had priced in the impact on company earnings.
In terms of policy, liquidity conditions improved over the month as central banks and governments reacted quickly via monetary and fiscal backstop initiatives. Most notable was the US Federal Reserve's decision to extend their bond purchasing program to investment grade credit, which significantly improved liquidity conditions in global credit markets. From a cyclical perspective, our expectation is that economic news will be negative as it tends to be lagging in nature, and from an overall sentiment/risk perspective our indicators showed an improvement (decline in risk), although risk indicators such as the VIX remain at elevated levels.
×